Sfoglia per AUTORE
CUSATO J
Collezione AOU San Luigi di Orbassano

  

Items : 27

How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWH. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2025 Jan 13;14(1):82. doi: 10.3390/antiox14010082.
2025
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Lupo C; Rainoldi A; Di Perri G; Bonora S; Trevisan G; Cuomo S; Tettoni MC; Chiara F; Mula J; Antonucci M; Bianco G; Accardo G; Palermiti A; Ferrara M; Manca A; Mulasso A; Cusato J;

Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116686. doi: 10.1016/j.biopha.2024.116686. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Luxardo N; Imperiale D; De Cori D; Vischia F; Nicolò A; Palermiti A; Antonucci M; Billi M; Valz C; Chiara F; Mula J; Cusato J; Manca A;

Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

Boglione L; D'Avolio A; De Nicolò A; Lupia T; Stroffolini G; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Cusato J;

Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

Rainoldi A; D'Avolio A; Di Perri G; Lupo C; Bonora S; Trevisan G; Cuomo S; Maddalone MG; Tettoni MC; Mula J; Chiara F; Bianco G; Accardo G; Palermiti A; Antonucci M; Ferrara M; Manca A; Mulasso A; Cusato J;

COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Bonora S; Di Perri G; Ferrara M; De Vivo ED; Maiese D; Antonucci M; Chiara F; Costanzo M; Mula J; Manca A; Palermiti A; Cusato J;

Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Jul;163:114790. doi: 10.1016/j.biopha.2023.114790. Epub 2023 Apr 29.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

De Nicolò A; De Rosa FG; Di Perri G; Simiele M; Cusato J; Maiese D; Palermiti A; Manca A; Chiara F; Mula J; D'Avolio A;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;

A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2022 Dec;156:113899. doi: 10.1016/j.biopha.2022.113899. Epub 2022 Oct 21.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

De Filippis G; Vischia F; De Cori D; Cusato J; D'Avolio A; De Nicolò A; Imperiale D; Maiese D; Mula J; Zeaiter S; Palermiti A; Manca A; Chiara F;

Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers. in The Journal of steroid biochemistry and molecular biology / J Steroid Biochem Mol Biol. 2021 Jun;210:105854. doi: 10.1016/j.jsbmb.2021.105854. Epub 2021 Feb 22.
2021
ASL Città di Torino
AOU San Luigi di Orbassano

Poli G; Di Perri G; Lembo D; Biasi F; D'Avolio A; Cusato J; Civra A; Boglione L; Caccia C; Leoni V;

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
AOU San Luigi di Orbassano

Antonucci M; D'Avolio A; Manca A; Avataneo V; Cusato J; Allegra S; De Francia S; De Nicolò A;

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;

Pharmacogenetic of voriconazole antifungal agent in pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2018 Jul 1;19(11):913-925. doi: 10.2217/pgs-2017-0173. Epub 2018 Jun 19.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Perri GD; Avataneo V; Nicolò A; Cusato J; Carcieri C; Francia S; Pirro E; Fatiguso G; Allegra S;

Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; D'Avolio A; Carcieri C; Carcieri C; Tomasello C; Simiele M; De Nicolò A; Avataneo V; Canzoneri L; Cusato J; Di Perri G; D'Avolio A;

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;

Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A; Allegra S; Massano D; De Francia S; Longo F; Piccione F; Pirro E; Cusato J; D'Avolio A; Piga A;

Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia. in Journal of neurovirology / J Neurovirol. 2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Calcagno A; Trunfio M; Imperiale D; Di Perri G; Sala A; Ferrara M; Audagnotto S; Pesci Kincer L; Cusato J; Martini C; Joseph SB; Ghisetti V; Romito A; Trunfio M; Joseph SB; Ghisetti V; Romito A; Martini C; Cusato J; Audagnotto S; Pesci Kincer L; Ferrara M; Sala A; Imperiale D; Di Perri G; Calcagno A;

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;

Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox AUC efficacy cutoff and role of pharmacogenetics. in European journal of clinical pharmacology / Eur J Clin Pharmacol. 2016 Sep;72(9):1155-7. doi: 10.1007/s00228-016-2070-9. Epub 2016 May 18.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Massano D; Piga A; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2016 Nov;68(11):1417-1421. doi: 10.1111/jphp.12638. Epub 2016 Sep 27.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Massano D; Pirro E; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Pirro E; Arduino A; Cusato J; Massano D; Longo F; De Francia S; Allegra S; D'Avolio A;

Role of pharmacogenetics on deferasirox AUC and efficacy. in Pharmacogenomics / Pharmacogenomics. 2016 Apr;17(6):561-72. doi: 10.2217/pgs-2015-0001. Epub 2016 Apr 4.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; De Francia S; Allegra S; Cusato J;